ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

HPV Can Affect Response To Radiation Therapies

September 28, 2012

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

March 11, 1977

In Brief: NCI Would Get Extra $115 Million Over Three Years Under Budget Amendment By Alabama Senator

June 4, 1982

Decade-Long Cover-up?

January 6, 1995

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012